Bacteria use a variety of methods to fight off the medications designed to destroy them. Ribosome-modifying enzymes are one of these weapons that are most common and these enzymes are becoming more widespread
According to new research, people who take proton pump inhibitors for four and a half years or more may have a higher risk of dementia than people who do not take these medications. This study does not establish that acid reflux medications cause dementia; rather, it demonstrates a correlati
Doctors are unable to establish the cause of cancer in a small percentage of cancer patients. This makes choosing a treatment for those patients considerably more challenging, because many cancer medications are often produced for specific cancer types.
Researchers created and validated a tool called PRESTO that identifies psoriasis patients who have a higher chance of developing psoriatic arthritis and may therefore benefit from preventative medications
According to a recent study published in the Proceedings of the National Academy of Sciences (PNAS), researchers at NYU College of Dentistry's Pain Research Centre have created a gene therapy that cures chronic pain by unintentionally controlling a particular sodium ion channel.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
Researchers from the Salk Institute and the National Institutes of Health have identified the molecular pathways by which the human immunodeficiency virus (HIV) develops resistance to dolutegravir, one of the most potent antiviral medications now being used in clinical use to treat HIV.
According to Rutgers researchers, the majority of people with multiple sclerosis (MS) choose oral medications to treat the chronic and progressive neurological illness. This is likely due to a variety of variables, including convenience, consumer promotion, and approval by health insurers.
Many of the medications we use to treat cancer and infectious disease are - or are derived from natural chemicals, but it's difficult to know how nature assembles them.
Because the disease is becoming increasingly resistant to existing medications, a group of UCF researchers is attempting to use cancer pharmaceuticals to accelerate the development of new, life-saving malaria treatments. The study's findings were published in the journal ACS Infectious Disea
A group of UCF researchers are looking to use cancer pharmaceuticals to hasten the development of fresh, life-saving malaria treatments because the disease is getting more and more resistant to existing medications.